ETH Zurich Spin-Off greenTEG Offers to Sponsor Covid-19 Research with its Unique Fever-Monitor

The current Covid-19 global pandemic raises many challenges for individuals, companies, and governments. As the disease has spread to nearly 200 countries, the devastating health and socioeconomic impact of the pandemic becomes evident. Consequently, these developments have sparked wide-scale initiatives by companies and individuals to develop new tools like vaccines, protective equipment and monitoring solutions to assist in the battle of this unexpected crisis.

Fever is the most common initial symptom1 of the virus and this is where greenTEG wants to help. Our non-invasive and continuous core body temperature monitoring patch enables early fever detection using only skin contact. The accuracy of the device has been verified in multiple clinical studies.

We believe that our solution can reduce the strain on the healthcare system by monitoring healthcare professionals exposed to the virus and by additionally monitoring general ward patients, thus freeing up precious nursing resources. The device can further be effective for scientists researching the influence of the novel Coronavirus on the body temperature (e.g. temperature patterns).

greenTEG is offering its expertise and its technology as a contribution to overcoming the current pandemic faster and with less sacrifice. greenTEG is willing to sponsor sensors for selected medical research on Covid-19 patients or healthcare professionals. At the same time, greenTEG is looking for partners capable of bringing its continuous and non-invasive core body temperature monitoring solution to the market as quickly as possible.

Interested researchers or clinicians, as well as potential commercialisation partners, please fill out the enquiry form attached to this page for more information.

More About This Company